News
Interview with the Photographers of the Exhibition "Living With": Antoine Martin and John Kalapo
From September 3 to 30, 2025, Quai Wilson in Geneva will host the photographic exhibition *Living With*. Created in collaboration with the NCD Policy Lab, it showcases the daily lives of people living with type 1 diabetes in Geneva and Bamako. Meet the photographers Antoine Martin and John Kalapo.
“Living With”: Perspectives on Type 1 Diabetes, from Geneva to Bamako
The exhibition ‘Living With’ invites the public to discover the daily lives of people living with type 1 diabetes in Geneva, Switzerland, and in Bamako, Mali, highlighting their challenges, strength, and resilience.
Santé Diabète releases its 2024 annual report: a year rich in actions and results
We are proud to present our 2024 Annual Report, a testament to Santé Diabète’s ongoing commitment to improving diabetes prevention and care, particularly in Africa.
Strengthening healthcare systems in the face of comorbidities: 4 years of action in Mali, Burkina Faso and the Comoros
Since 2021, Santé Diabète has been leading an ambitious project in Mali, Burkina Faso, and the Comoros. The goal: to improve the quality of life of people living with diabetes, HIV, and tuberculosis by providing integrated care for these often interconnected diseases.
Nutrition for Growth 2025 scientific conference: towards global solutions to malnutrition and NCDs
On March 26, 2025, as part of the Nutrition for Growth (N4G) summit, a scientific conference co-organized by Agence Française de Développement (AFD) and its partners was held in Paris. The final session, proposed by Santé Diabète and the World Diabetes Foundation, and devoted to the issues of malnutrition, obesity and non-communicable diseases (NCDs),...
Biosimilar Insulin Significantly Lowers HbA1c in Mali, But Access Remains a Challenge
Our new study published in Diabetic Medicine has demonstrated significant improvements in glycaemic control among children and young adults living with Type 1 Diabetes (T1D) in Mali following the introduction of biosimilar glargine, a long-acting analogue insulin.
Public health is challenged by lobbies : “Decisions should not be imposed by economical interests, but by those of consumers, patients.”
Should public health decisions be guided by the interests of consumers and patients or by the economic imperatives of companies? In a joint interview with Le Monde, Serge Hercberg, a nutritionist and initiator of the Nutri-Score, and Stéphane Besançon, director of the NGO Santé Diabète and advocate for insulin access, denounce the pressures exerted by…
Public health vs. lobbies: a necessary fight for consumers and patients
Should public health decisions be guided by the interests of consumers and patients, or by the economic imperatives of companies? Read the joint interview for Le Monde of Serge Hercberg, nutritionist and initiator of the Nutri-Score, and Stéphane Besançon, director of the NGO Santé Diabète and advocate for insulin access.
Cyclone Chido in Mayotte: the State must guarantee continuity of care for people living with diabetes
Grenoble, January 2, 2025 - The devastating passage of cyclone Chido on December 14, 2024 has plunged the Mayotte archipelago into a humanitarian emergency. A French overseas department in the Indian Ocean, Mayotte is home to more than 320,000 inhabitants, 10% of whom live with diabetes, a rate twice that of mainland France.
À l’approche de la Journée Mondiale du Diabète, les entreprises pharmaceutiques telles que Eli Lilly, Novo Nordisk et Sanofi doivent rendre les stylos à insuline disponibles à 1 dollar par stylo.
On November 14, 2024, the NGO Santé Diabète joined Médecins Sans Frontières Access Campaign, T1International, and Treatment Action Campaign in a demonstration outside Novo Nordisk’s headquarters in Sandton, South Africa, calling on the company to make insulin pens available at $1 per pen.
